Metformin / Dapagliflozin Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: (dapagliflozin/metformin): 5 mg/500 mg, 5 mg/1000 mg, 10 mg/500 mg, 10 mg/1000 mg
Reference Brands: Xigduo XR(US and EU), Metdap XR (India)
Category: Diabetes
Dapagliflozin/metformin (Xigduo XR) combines two mechanisms: dapagliflozin, an SGLT2 inhibitor, reduces blood glucose by increasing urinary glucose excretion, while metformin decreases hepatic glucose production and improves insulin sensitivity. Benefits include improved glycemic control, weight loss, and reduced cardiovascular risk in type 2 diabetes patients.
Product Description:
In the US, dapagliflozin/metformin (Xigduo XR) was approved by the FDA in February 2014 for type 2 diabetes as an adjunct to diet and exercise, with a warning to stop temporarily before surgery to reduce ketoacidosis risk. In the EU, Xigduo received marketing authorization in January 2014, and Ebymect in November 2015, for glycemic control in adults when metformin alone is inadequate. The EMA expanded metformin use in 2016 to patients with moderate kidney impairment (GFR 30–59 ml/min), with dose adjustments and monitoring for lactic acidosis. For sourcing, check Pharmatradz.com for supplier details and availability
Metformin / Dapagliflozin Tablets — third party manufacturing & bulk supply
Metformin / Dapagliflozin Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Metformin / Dapagliflozin Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Metformin / Dapagliflozin Tablets →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
The combination of Metformin and Dapagliflozin is used to manage Type 2 diabetes mellitus. It helps control blood sugar by combining metformin’s effect of reducing hepatic glucose production and improving insulin sensitivity with dapagliflozin’s effect of increasing glucose excretion through the urine.
This combination contains two active ingredients: Metformin, a biguanide antihyperglycemic agent, and Dapagliflozin, an SGLT2 inhibitor. Together, they provide complementary mechanisms to improve glycemic control.
The combination is marketed under trade names such as Xigduo XR and Xigduo, depending on the region.
Metformin / Dapagliflozin is manufactured by AstraZeneca, with some regional generics produced by local pharmaceutical companies.
The generic name is Metformin / Dapagliflozin.
Brand names include Xigduo XR (USA/EU) and Xigduo (India/EU).
It is manufactured in the USA, EU, and India, and distributed globally in multiple markets.
Related Products
Pioglitazone Hydrochloride 150Mg Tablet
Strength:
15 mg, 30 mg, 45 mg
Form: Tablets
Reference Brands: Actos (USA)
View Details
Nateglinide
Strength:
60 mg, 120 mg, 180 mg
Form: Tablets
Reference Brands: Starlix (USA)
View Details
Miglitol
Strength:
25 mg, 50 mg, 100 mg
Form: Tablets
Reference Brands: Glyset (USA), Diastabol (EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
